Swu Ejournals Systemmetadata only
Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer's Disease: Targeting mTOR and NGFR Pathways
drug repurposing, mammalian target of rapamycin, nerve growth factor receptor, alzheimer's disease, computational analysis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 320931
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.